EN
R&D

R&D Center

We focus on the development of regenerative medical treatments
and high-functional bio materials with our stem cell differentiation technology
and Exosome mass production technology as our core competitiveness.
We lead the global market by developing technology
in various fields such as cutting-edge cosmeceuticals,
skin disease treatments, and bio-formulation.
01 Development of advanced Cosmeceutical products based on exosome mass production technology.
02 Development of functional cosmetics using peptide, protein, biopolymer, and natural extracts.
03 Development of commercialization technology for skin disease treatments that are effective for skin regeneration and prevention of aging through the use of self-stem cell differentiation technology.
04 Research on the next-generation bio-research technology to improve the effectiveness of bio-products and to compensate for the weaknesses of storage and administration.

Patents applied and
registered

We will lead to create optimal customer value and trust with innovative products and services with ingredient registration and various patents.
  • Patent registration of UC-MSC exosome
    Patent registration of UC-MSC exosome.
  • Patent registration of Neural Stem Cell Conditioned Media
    Patent registration of Neural Stem Cell Conditioned Media.
  • INCI registration of UC-MSC conditioned media
    INCI registration of UC-MSC conditioned media.
  • INCI registration of Neural Stem Cell Conditioned Media
    INCI registration of Neural Stem Cell Conditioned Media.
  • INCI registration of Induced Neural Stem Cell Conditioned Media
    INCI registration of Induced Neural Stem Cell Conditioned Media.
BIO Research Center of HansPharma Co. Ltd. has established with 30 major facilities such as stem cell culture room and laboratory for cell characteristics, active analysis (200㎡ space in head office located in Munjeong-dong, Songpa-gu, Seoul), BioSafety Clean Bench (BSC), Co2 incubator, Chemi-Doc, PCR, and Ultracentrifuge.